Fatigue Item Response among Hemoglobin-Normalized Patients with Paroxysmal Nocturnal Hemoglobinuria: PEGASUS Trial Results at 16 and 48 Weeks

Fatigue Item Response among Hemoglobin-Normalized Patients with Paroxysmal Nocturnal Hemoglobinuria: PEGASUS Trial Results at 16 and 48 Weeks

<b>Background.</b> A common symptom of paroxysmal nocturnal hemoglobinuria (PNH) is fatigue, which in some patients can be severe. Eculizumab (Ecu) has proven efficacy in controlling intravascular hemolysis, but commonly results in persistent anemia and fatigue. Pegcetacoplan’s (Peg) eff...

Full description

Bibliographic Details
Main Authors: Carolyn E. Schwartz, Katrina Borowiec, Jinny Min, Jesse Fishman
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Journal of Clinical Medicine
Subjects:
paroxysmal nocturnal hemoglobinuria
fatigue
clinical normalization
item response
Online Access:https://www.mdpi.com/2077-0383/13/6/1703

Internet

https://www.mdpi.com/2077-0383/13/6/1703

Similar Items